Sanketh Produttur, MD

Article

Consider this SGLT2 inhibitor for patients with HF with preserved ejection fraction

Author:

Sanketh Produttur, MD

The addition of empagliflozin to usual therapy reduced hospitalization risk, regardless of patients’ diabetes status.

• Read More